| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f88f84fc279fe5d0b9b5ec3c88c2e2b2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate |
1981-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1983-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af4e290ef048c35d95b4813b1496ff93 |
| publicationDate |
1983-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4377582-A |
| titleOfInvention |
2-Phenyl-4-[cis-2,5-dimethyl-4-(2-pyridinyl)-1-piperazinyl]quinazoline |
| abstract |
Novel hypotensive agents are disclosed which are quinazolines substituted in the 2 and 4 position having the general formula: ##STR1## wherein Q is a secondary amine radical illustrated by loweralkanolylamino or a tertiary amine radical such as pyrrolidinyl, piperidinyl or piperazinyl, any of which may be substituted by various groups such as loweralkanolyl. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7928107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006173018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8283354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011021495-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004248890-A1 |
| priorityDate |
1979-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |